{
    "info": {
        "nct_id": "NCT04099251",
        "official_title": "A Phase 3, Randomized, Double-Blind Study of Adjuvant Immunotherapy With Nivolumab Versus Placebo After Complete Resection of Stage IIB/C Melanoma",
        "inclusion_criteria": "* Had a negative sentinel lymph node biopsy\n* Participant has not been previously treated for melanoma\n* ECOG 0 or 1\n* Participants must have been diagnosed with histologically confirmed, Resected, Stage IIB/C cutaneous melanoma\nHealthy volunteers allowed\nMust have minimum age of 12 Years",
        "exclusion_criteria": "* History of ocular or mucosal melanoma.\n* Pregnant or nursing women\n* Participants with active known or suspected autoimmune disease\n* Known history of allergy or hypersensitivity to study drug components\n* Prior treatment with an anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CD137, anti-CTLA-4 antibody, or agents that target IL-2 pathways, T-cell stimulators, or checkpoint pathways\n\nOther protocol defined inclusion/exclusion criteria apply.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Had a negative sentinel lymph node biopsy",
            "criterions": [
                {
                    "exact_snippets": "negative sentinel lymph node biopsy",
                    "criterion": "sentinel lymph node biopsy",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant has not been previously treated for melanoma",
            "criterions": [
                {
                    "exact_snippets": "has not been previously treated for melanoma",
                    "criterion": "prior treatment for melanoma",
                    "requirements": [
                        {
                            "requirement_type": "absence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants must have been diagnosed with histologically confirmed, Resected, Stage IIB/C cutaneous melanoma",
            "criterions": [
                {
                    "exact_snippets": "diagnosed with histologically confirmed",
                    "criterion": "melanoma diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": "histologically confirmed"
                        }
                    ]
                },
                {
                    "exact_snippets": "Resected",
                    "criterion": "melanoma resection status",
                    "requirements": [
                        {
                            "requirement_type": "resection status",
                            "expected_value": "resected"
                        }
                    ]
                },
                {
                    "exact_snippets": "Stage IIB/C",
                    "criterion": "melanoma stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "IIB",
                                "IIC"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "cutaneous melanoma",
                    "criterion": "melanoma type",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": "cutaneous"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 12 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 12 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 12,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG 0 or 1",
            "criterions": [
                {
                    "exact_snippets": "ECOG 0 or 1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "Other protocol defined inclusion/exclusion criteria apply.",
            "criterions": [
                {
                    "exact_snippets": "Other protocol defined inclusion/exclusion criteria apply.",
                    "criterion": "other protocol defined inclusion/exclusion criteria",
                    "requirements": [
                        {
                            "requirement_type": "applicability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of ocular or mucosal melanoma.",
            "criterions": [
                {
                    "exact_snippets": "History of ocular or mucosal melanoma.",
                    "criterion": "ocular melanoma",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "History of ocular or mucosal melanoma.",
                    "criterion": "mucosal melanoma",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known history of allergy or hypersensitivity to study drug components",
            "criterions": [
                {
                    "exact_snippets": "Known history of allergy or hypersensitivity to study drug components",
                    "criterion": "allergy or hypersensitivity to study drug components",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pregnant or nursing women",
            "criterions": [
                {
                    "exact_snippets": "Pregnant ... women",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "pregnancy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "nursing women",
                    "criterion": "nursing status",
                    "requirements": [
                        {
                            "requirement_type": "nursing",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with active known or suspected autoimmune disease",
            "criterions": [
                {
                    "exact_snippets": "active known or suspected autoimmune disease",
                    "criterion": "autoimmune disease",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "diagnosis status",
                            "expected_value": [
                                "known",
                                "suspected"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior treatment with an anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CD137, anti-CTLA-4 antibody, or agents that target IL-2 pathways, T-cell stimulators, or checkpoint pathways",
            "criterions": [
                {
                    "exact_snippets": "Prior treatment with an anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CD137, anti-CTLA-4 antibody, or agents that target IL-2 pathways, T-cell stimulators, or checkpoint pathways",
                    "criterion": "prior treatment with specified immunotherapy agents",
                    "requirements": [
                        {
                            "requirement_type": "history of treatment",
                            "expected_value": [
                                "anti-PD-1 antibody",
                                "anti-PD-L1 antibody",
                                "anti-PD-L2 antibody",
                                "anti-CD137 antibody",
                                "anti-CTLA-4 antibody",
                                "agents that target IL-2 pathways",
                                "T-cell stimulators",
                                "checkpoint pathway agents"
                            ]
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}